A Breakdown of Johnson & Johnson’s Major Sector Revenues Since 2Q17
As one of the largest pharmaceutical companies in the world, Johnson & Johnson (NASDAQ:$JNJ) operates in over 200 countries worldwide. In 2Q17, the company reported revenues of $18.8 billion, a 2% increase from $18.5 billion ... [Read]
Pfizer Files Lawsuit Against Johnson & Johnson
Drugmaker giant Pfizer Inc. (NYSE:$PFE) has officially filed a lawsuit against Johnson & Johnson (NYSE:$JNJ) on claims that its rival’s contracts with health insurers for blockbuster rheumatoid arthritis drug, Remicade, were anticompetitive and blocked sales ... [Read]
Pfizer’s Leukemia Drug Receives Green Light from FDA
The U.S. Food and Drug Administration officially approved Pfizer Inc’s (NYSE:$PFE) drug, Mylotarg, for the treatment of myeloid leukemia. The drug was given the green ligt to treat adults with newly diagnosed AML whose tumors ... [Read]
New Era of Cancer Treatment: Watch Out for Gilead
On August 30th, the U.S. Food and Drug Administration (FDA) approved Novartis AG (NASDAQ:$NVS)’s leukemia treatment, the first time that a highly anticipated new type of potent gene-modifying immunotherapy has been approved in the United ... [Read]
5 Ways the Gilead-Kite Acquisition Might be Profitable
While company acquisitions are sometimes cause for alarm among investors, Gilead Sciences’ (NASDAQ:$GILD) recent buyout of Kite Pharma (NASDAQ:$KITE) at $180 per share may have been a smart move toward long-term growth and profitable outcomes ... [Read]
The Man Who Spiked Up The Price of Daraprim, Martin Shkreli, Found Guilty of Three Counts of Securities Fraud
On Friday, August 4th, the infamous “Pharma bro” Martin Shkreli was found guilty of three counts of securities fraud. However, he was found not guilty of five other crimes he had been accused of regarding ... [Read]
Vertex Pharmaceuticals Shares Increased 24% Today
On July 18, Vertex Pharmaceuticals Inc. (NASDAQ:$VRTX) shares skyrocketed in an after hours trading session. This added about $8 billion to the Boston-based company’s value. What caused the increase? Shares of the company soared after ... [Read]
5 Pharma and Biotech Stocks to Watch as We Approach the Healthcare Sector Earnings
It seems like pharmaceutical and biotech stocks are making a comeback. And there are several, justifiable reasons for this improved performance. For starters, investors seem to be more comfortable with the drug pricing scenario and ... [Read]
Novartis’ Cutting-Edge Cancer Therapy Gains Critical Recommendation from FDA Advisory Committee
An advisory committee at the U.S. Food and Drug Administration (FDA) just gave a critical recommendation for pharmaceutical company Novartis’ (NYSE:$NVS) new cancer therapy. The data for the therapy, called CTL019 and developed to treat ... [Read]
Sanofi to Buy Protein Sciences For $650 Million
It has been announced that Sanofi (OTC:$SNYNF), a French pharmaceutical company, will be purchasing Protein Sciences, a privately-held U.S. vaccines biotech company, for $650 million. This deal indicates that Sanofi is going forward with its ... [Read]